Incidence of STP at 24 hours post‐operatively · women undergoing a diagnostic or operative laparoscopic gynaecological procedure
Subdiaphragmatic intraperitoneal local anaesthetic showed no clear difference in incidence of STP at 24 hours post‐operatively compared with control (moderate certainty).
1 finding from 1 review
Severity of STP at 24 hours post‐operatively · women undergoing a diagnostic or operative laparoscopic gynaecological procedure
1 finding from 1 review
Adverse events · women undergoing a diagnostic or operative laparoscopic gynaecological procedure
1 finding from 1 review
Analgesia usage · women undergoing a diagnostic or operative laparoscopic gynaecological procedure
1 finding from 1 review
Complete cure, at least 3 months after the end of treatment · People with American cutaneous leishmaniasis
Thermotherapy one session (at 50 ºC for 30 seconds) leads to lower complete cure, at least 3 months after the end of treatment compared with meglumine antimoniate (20 mg Sb5/kg/day (high certainty).
1 finding from 1 review
Adverse effects · People with American cutaneous leishmaniasis
1 finding from 1 review
Recurrence ‐ not measured · People with American cutaneous leishmaniasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adherence to iron chelation therapy (%, SD)
1 finding from 1 review
Adherence to iron chelation therapy (%, SD)
1 finding from 1 review
SAE (chelation‐related) (n/N)
1 finding from 1 review
SAEs
It is very uncertain whether summary of findings: Comparison 3 ‐ deferiprone (DFP) changes total SAEs compared with deferasirox (DFX) (very low certainty).
1 finding from 1 review
All‐cause mortality (n/N)
Summary of findings: Comparison 3 ‐ deferiprone (DFP) showed no clear difference in all‐cause mortality (n/N) compared with deferasirox (DFX) (low certainty).
1 finding from 1 review
Sustained adherence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
SAEs
It is very uncertain whether summary of findings: Comparison 1 ‐ deferiprone (DFP) changes total reported SAEs (from therapy, disease, non‐adherence) compared with deferoxamine (DFO) (very low certainty).
1 finding from 1 review
All‐cause mortality
It is very uncertain whether summary of findings: Comparison 1 ‐ deferiprone (DFP) changes all‐cause mortality compared with deferoxamine (DFO) (very low certainty).
1 finding from 1 review
Sustained adherence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
Proportion of participants cleared or almost cleared ‐ · chronic palmoplantar pustulosis
It is very uncertain whether triamcinolone acetonide 0.1% cream with occlusive dressing changes proportion of participants cleared or almost cleared ‐ compared with clobetasol cream 0.05% cream (very low certainty).
1 finding from 1 review
Proportion of participants with adverse effects serious or severe enough to have caused withdrawal ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found